Antenatal screening providers should be developing plans to replace the national printed family origin questionnaire from spring 2021 onwards.
Amanda was appointed national programme manager of the NHS Sickle Cell and Thalassaemia Screening Programme in July 2019. She brings knowledge and experience from midwifery, midwifery supervision and public health and is passionate about providing high-quality care for women, babies and their families. Amanda’s previous roles have included being a senior quality assurance advisor in the Midlands and East region, a head of midwifery and associate nurse director, matron, birth centre and community team manager. She is a professional midwifery advocate jointly providing expert advice on professional nursing and midwifery subjects within PHE as part of the Nursing and Midwifery Revalidation Group.
This blog article gives providers guidance on sickle cell and thalassaemia screening for women who are pregnant via egg donation.
Related content and links
The PHE Screening team
Public Health England (PHE) provides support and advice to the NHS-led national screening programmes. These programmes identify apparently healthy people who may be at increased risk of a disease or condition, enabling earlier treatment and informed decisions. PHE also hosts the UK National Screening Committee (UK NSC) secretariat and supports the work of the committee.
Find out more about PHE Screening and this blog.
Watch our 44 second video for an overview of how the blog works.
Comments and moderation
- NHS diabetic eye screening services and the National Diabetes Audit join forces to evaluate diabetes care 16 September 2021
- Report published marking 25 years of UK National Screening Committee 15 September 2021
- Valuable feedback from newborn blood spot failsafe solution (NBSFS) survey 14 September 2021